Article(id=1326651753577165126, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326651677442159392, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2025.12.003, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1761580800000, receivedDateStr=2025-10-28, revisedDate=null, revisedDateStr=null, acceptedDate=null, acceptedDateStr=null, onlineDate=1794228026049, onlineDateStr=2026-11-09, pubDate=1765296000000, pubDateStr=2025-12-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1794228026049, onlineIssueDateStr=2026-11-09, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1794228026049, creator=13701087609, updateTime=1794228026049, updator=13701087609, issue=Issue{id=1326651677442159392, tenantId=1146029695717560320, journalId=1319690329412173987, year='2025', volume='46', issue='12', pageStart='1201', pageEnd='1311', issueExtLink='null', onlineDate='null', pubDate='1765296000000', pubDateStr='2025-12-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1794228007890, creator='13701087609', updateTime=1794272794012, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1326839524379964187, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326651677442159392, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1326839524379964188, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1326651677442159392, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=1213, endPage=1220, ext={EN=ArticleExt(id=1326651755103891784, articleId=1326651753577165126, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Research advances in pharmacotherapy for Kawasaki disease, columnId=1325221107665612978, journalTitle=World Clinical Drug, columnName=Topic, runingTitle=null, highlight=null, articleAbstract=

Kawasaki disease(KD) is an acute, self-limiting, multi-system vasculitic syndrome. It is the leading cause of acquired heart disease in children in developed countries. Coronary artery aneurysms are its most serious complication and can trigger long-term cardiovascular events. In recent years, the understanding of the pathogenesis of KD has shifted from the single pathogen hypothesis to an immune-disordered disease caused by microorganisms. Based on the individualized treatment model of KD with risk stratification, this paper systematically reviewed the latest advances in pharmacotherapy for KD, and prospected the future research directions, aiming to provide reference for clinical medication.

, authors=Huijing WANG, Weihua HUANG*, Huijun ZHAO, authorsList=Huijing WANG, Weihua HUANG, Huijun ZHAO, authorCompany=null, correspAuthors=Weihua HUANG, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1326651755410075977, articleId=1326651753577165126, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=川崎病药物治疗研究进展, columnId=1325221107824996532, journalTitle=世界临床药物, columnName=医药专论, runingTitle=null, highlight=null, articleAbstract=

川崎病(Kawasaki disease,KD)是一种急性、自限性、多系统血管炎性综合征,是发达国家儿童后天性心脏病的首要病因,冠状动脉瘤(coronary artery aneurysm)是其最严重的并发症,可引发远期心血管事件。近年来,对于KD发病机制的认知已从单一病原体假说,转变为将其视为一种由微生物引发的免疫失调性疾病。现基于风险分层的KD个体化治疗模式,系统综述KD药物治疗最新进展,并针对未来研究方向进行展望,以期为临床用药提供参考。

, authors=王慧婧, 黄卫华*, 赵惠君, authorsList=王慧婧, 黄卫华, 赵惠君, authorCompany=null, correspAuthors=黄卫华, authorNote=

王慧婧,主治医师,研究方向:儿童血液病。

, correspAuthorsNote=
黄卫华,主任医师,研究方向:儿童血液病。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=skYTg178UVi481omhQs2Bg==, magXml=PDs3n4GGv54Ecf8SWlVpKA==, pdfUrl=null, pdf=A1+wbBlQ4F+uNxDnrp1idA==, pdfFileSize=1091236, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=eCZAQqnL7H0ND/Te+ZNbMg==, mapNumber=null, fund=null)}, authors=[Author(id=1326651756211188046, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326651756307657040, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756211188046, language=EN, stringName=Huijing WANG, firstName=Huijing, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326651756374765905, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756211188046, language=CN, stringName=王慧婧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028, bio={"content":"

王慧婧,主治医师,研究方向:儿童血液病。

"}, bioImg=null, bioContent=

王慧婧,主治医师,研究方向:儿童血液病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326651756001472842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, xref=null, ext=[AuthorCompanyExt(id=1326651756009861451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China), AuthorCompanyExt(id=1326651756035027276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028)])]), Author(id=1326651756471234899, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326651756634812757, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756471234899, language=EN, stringName=Weihua HUANG, firstName=Weihua, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326651756852916566, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756471234899, language=CN, stringName=黄卫华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326651756001472842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, xref=null, ext=[AuthorCompanyExt(id=1326651756009861451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China), AuthorCompanyExt(id=1326651756035027276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028)])]), Author(id=1326651756924219736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326651757071020378, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756924219736, language=EN, stringName=Huijun ZHAO, firstName=Huijun, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326651757171683675, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756924219736, language=CN, stringName=赵惠君, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326651756001472842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, xref=null, ext=[AuthorCompanyExt(id=1326651756009861451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China), AuthorCompanyExt(id=1326651756035027276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028)])])], keywords=[Keyword(id=1326651757293318492, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, language=EN, orderNo=1, keyword=Kawasaki disease), Keyword(id=1326651757364621661, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, language=EN, orderNo=2, keyword=vasculitis), Keyword(id=1326651757431730527, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, language=EN, orderNo=3, keyword=pharmacotherapy), Keyword(id=1326651757486256480, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, language=EN, orderNo=4, keyword=intravenous immunoglobulin), Keyword(id=1326651757570142562, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, language=EN, orderNo=5, keyword=coronary artery aneurysm), Keyword(id=1326651757637251427, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, language=CN, orderNo=1, keyword=川崎病), Keyword(id=1326651757700165988, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, language=CN, orderNo=2, keyword=血管炎), Keyword(id=1326651759486939494, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, language=CN, orderNo=3, keyword=药物治疗), Keyword(id=1326651759826678119, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, language=CN, orderNo=4, keyword=静脉注射免疫球蛋白), Keyword(id=1326651759948312936, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, language=CN, orderNo=5, keyword=冠状动脉瘤)], refs=[Reference(id=1326651760111890793, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=RAJASEKARAN K, DURAIYARASAN S, ADEFUYE M,et al. Kawasaki disease and coronary artery involvement: a narrative review[J]. Cureus, 2022, 14(8): e28358., articleTitle=null, refAbstract=null), Reference(id=1326651760174805354, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=MADDOX RA, PERSON MK, KENNEDY JL, et al.Kawasaki disease and Kawasaki disease shock syndrome hospitalization rates in the United States, 2006—2018[J].Pediatr Infect Dis J, 2021, 40(4): 284-288., articleTitle=null, refAbstract=null), Reference(id=1326651760325800299, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=WATTS RA, HATEMI G, BURNS JC, et al. Global epidemiology of vasculitis[J]. Nat Rev Rheumatol, 2022,18(1): 22-34., articleTitle=null, refAbstract=null), Reference(id=1326651760418074988, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=HOUSKA N, ALBERTZ M, ING R. Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association[J]. J Cardiothorac Vasc Anesth, 2025, 39(5): 1103-1105., articleTitle=null, refAbstract=null), Reference(id=1326651760493572461, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=HARA T, NAKASHIMA Y, SAKAI Y, et al. Kawasaki disease: a matter of innate immunity[J]. Clin Exp Immunol,2016, 186(2): 134-143., articleTitle=null, refAbstract=null), Reference(id=1326651760615207278, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=NADIG P, JOSHI V, PILANIA R, et al. Intravenous immunoglobulin in Kawasaki disease - evolution and pathogenic mechanisms[J]. Diagnostics, 2023, 13(14):2338., articleTitle=null, refAbstract=null), Reference(id=1326651760753619311, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=CHRIST A, LATZ E. Deciphering how NLRP3 incites the stromal response in Kawasaki vasculitis[J]. Circ Res,129(9): 840-842., articleTitle=null, refAbstract=null), Reference(id=1326651761030443376, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=LEE JK. Hygiene hypothesis as the etiology of Kawasaki disease: dysregulation of early B cell development[J]. Int J Mol Sci, 2021, 22(22): 12334., articleTitle=null, refAbstract=null), Reference(id=1326651761110135153, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=HALYABAR O, FRIEDMAN KG, SUNDEL RP, et al.Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms[J]. Pediatr Rheumatol Online J, 2021, 19(1): 31., articleTitle=null, refAbstract=null), Reference(id=1326651761235964274, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=QIU Y, ZHANG Y, LI Y, et al. Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis[J]. Front Cardiovasc Med, 2022, 9: 981010., articleTitle=null, refAbstract=null), Reference(id=1326651761307267443, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=KIM JJ, KIM HJ, YU JJ, et al. IgA levels are associated with coronary artery lesions in Kawasaki disease[J]. Korean Circ J, 2021, 51(3): 267-268., articleTitle=null, refAbstract=null), Reference(id=1326651761382764917, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHANG Y, JIA C, GUO M, et al. Platelet-monocyte aggregate instigates inflammation and vasculopathy in Kawasaki disease[J]. Adv Sci, 2025, 12(5): e2406282., articleTitle=null, refAbstract=null), Reference(id=1326651761479233910, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=KOCATURK B, LEE Y, NOSAKA N, et al. Platelets exacerbate cardiovascular inflammation in a murine model of Kawasaki disease vasculitis[J]. JCI Insight, 2023, 8(14):e169855., articleTitle=null, refAbstract=null), Reference(id=1326651761542148471, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=KINUMAKI A, SEKIZUKA T, HAMADA H, et al.Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis[J]. Front Microbiol, 2015,6: 824., articleTitle=null, refAbstract=null), Reference(id=1326651761609257336, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=KHAN I, LI X ANG, LAW B, et al. Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children[J]. Future Microbiol, 2020,15(8): 591-600., articleTitle=null, refAbstract=null), Reference(id=1326651761693143417, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=JENA PK, ARDITI M, NOVAL RIVAS M. Gut microbiota alterations in patients with Kawasaki disease[J]. ATVB,2025, 45(3): 345-358., articleTitle=null, refAbstract=null), Reference(id=1326651761793806714, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=YANG Q, TANG W, REN J, et al. Unveiling the gut-heart potential connection: microbiota's role in Kawasaki disease and coronary artery lesions[J]. Front Cell Infect Microbiol,2025, 15: 1560083., articleTitle=null, refAbstract=null), Reference(id=1326651761936413051, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=WANG F, QIAN F, ZHANG Q, et al. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease[J]. Front Immunol, 2023, 14:1124118., articleTitle=null, refAbstract=null), Reference(id=1326651762062242172, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=中华医学会儿科学分会心血管学组. 川崎病诊断和急性期治疗专家共识[J]. 中华儿科杂志, 2022, 60(8): 6-13., articleTitle=null, refAbstract=null), Reference(id=1326651762183876989, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[20], rfOrder=19, authorNames=null, journalName=null, refType=null, unstructuredReference=SALGADO AP, ASHOURI N, BERRY EK, et al. High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease[J]. J Pediatr, 2017, 185: 112-116., articleTitle=null, refAbstract=null), Reference(id=1326651763895153022, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[21], rfOrder=20, authorNames=null, journalName=null, refType=null, unstructuredReference=MCCRINDLE BW, ROWLEY AH, NEWBURGER JW, et al.Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017,135(17): e927-e999., articleTitle=null, refAbstract=null), Reference(id=1326651763966456191, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[22], rfOrder=21, authorNames=null, journalName=null, refType=null, unstructuredReference=FUKAZAWA R, KOBAYASHI J, AYUSAWA M, et al.JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Circ J, 2020,84(8): 1348-1407., articleTitle=null, refAbstract=null), Reference(id=1326651764067119488, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[23], rfOrder=22, authorNames=null, journalName=null, refType=null, unstructuredReference=MORENO E, GARCIA SD, BAINTO E, et al. Presentation and outcomes of Kawasaki disease in Latin American infants younger than 6 months of age: a multinational multicenter study of the REKAMLATINA network[J]. Front Pediatr,2020, 8: 384., articleTitle=null, refAbstract=null), Reference(id=1326651764134228353, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[24], rfOrder=23, authorNames=null, journalName=null, refType=null, unstructuredReference=CAMERON SA, CARR M, PAHL E, et al. Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease[J]. Arch Dis Child, 2019, 104(5):451-455., articleTitle=null, refAbstract=null), Reference(id=1326651764226503042, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[25], rfOrder=24, authorNames=null, journalName=null, refType=null, unstructuredReference=LOPEZ L, FROMMELT PC, COLAN SD, et al. Pediatric heart network echocardiographic Z scores: comparison with other published models[J]. J Am Soc Echocardiogr, 2021,34(2): 185-192., articleTitle=null, refAbstract=null), Reference(id=1326651764314583427, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[26], rfOrder=25, authorNames=null, journalName=null, refType=null, unstructuredReference=黄玉娟, 李夙凌, 田园, 等. 中国儿童川崎病诊疗循证指南(2023年)[J]. 中国当代儿科杂志, 2023, 25(12): 1198-1210., articleTitle=null, refAbstract=null), Reference(id=1326651764373303684, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[27], rfOrder=26, authorNames=null, journalName=null, refType=null, unstructuredReference=JIAO W, WEI L, JIAO F, et al. Very early onset of coronary artery aneurysm in a 3-month infant with Kawasaki disease:a case report and literature review[J]. Ital J Pediatr, 2023,49(1): 60., articleTitle=null, refAbstract=null), Reference(id=1326651764553658757, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[28], rfOrder=27, authorNames=null, journalName=null, refType=null, unstructuredReference=Bruggeman CW, Nagelkerke SQ, Lau W, et al. Reatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products[J]. Blood Adv,2020, 4(14): 3416-3426., articleTitle=null, refAbstract=null), Reference(id=1326651764641739142, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[29], rfOrder=28, authorNames=null, journalName=null, refType=null, unstructuredReference=VAN ANH KVY, SHAH S, Tremoulet AH. Hemolysis from intravenous immunoglobulin in obese patients with Kawasaki disease[J]. Front Pediatr, 2020, 8: 146., articleTitle=null, refAbstract=null), Reference(id=1326651764750791048, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[30], rfOrder=29, authorNames=null, journalName=null, refType=null, unstructuredReference=KIM GB, YU JJ, YOON KL, et al. Medium- or higher-dose acetylsalicylic acid for acute Kawasaki disease and patient outcomes[J]. J Pediatr, 2017, 184: 125-129., articleTitle=null, refAbstract=null), Reference(id=1326651764830482825, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[31], rfOrder=30, authorNames=null, journalName=null, refType=null, unstructuredReference=SUZUKI T, MICHIHATA N, HASHIMOTO Y, et al.Association between aspirin dose and outcomes in patients with acute Kawasaki disease: a nationwide retrospective cohort study in Japan[J]. Eur J Pediatr, 2023, 183(1): 415-424., articleTitle=null, refAbstract=null), Reference(id=1326651764910174602, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[32], rfOrder=31, authorNames=null, journalName=null, refType=null, unstructuredReference=DALLAIRE F, FORTIER-MORISSETTE Z, BLAIS S, et al. Aspirin dose and prevention of coronary abnormalities in Kawasaki disease[J]. Pediatrics, 2017, 139(6): e20170098., articleTitle=null, refAbstract=null), Reference(id=1326651764989866379, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[33], rfOrder=32, authorNames=null, journalName=null, refType=null, unstructuredReference=AMARILYO G, KOREN Y, BRIK SIMON D, et al. High-dose aspirin for Kawasaki disease: outdated myth or effective aid?[J]. Clin Exp Rheumatol, 2017, 35(Suppl 103):S209-S212., articleTitle=null, refAbstract=null), Reference(id=1326651765052780940, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[34], rfOrder=33, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHOU X, DONG R, WEI X, et al. Impact of different treatment strategies on therapeutic efficacy and biomarkers in children with IVIG-resistant Kawasaki disease: a retrospective cohort study[J]. Front Pharmacol, 2025, 16: 1602637., articleTitle=null, refAbstract=null), Reference(id=1326651765111501197, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[35], rfOrder=34, authorNames=null, journalName=null, refType=null, unstructuredReference=MARCHESI A, RIGANTE D, CIMAZ R, et al. Revised recommendations of the Italian society of pediatrics about the general management of Kawasaki disease[J]. Ital J Pediatr,2021, 47(1): 16., articleTitle=null, refAbstract=null), Reference(id=1326651765170221454, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[36], rfOrder=35, authorNames=null, journalName=null, refType=null, unstructuredReference=DE GRAEFF N, GROOT N, OZEN S, et al. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative[J].Rheumatology, 2019, 58(4): 672-682., articleTitle=null, refAbstract=null), Reference(id=1326651765241524623, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[37], rfOrder=36, authorNames=null, journalName=null, refType=null, unstructuredReference=AE R, ABRAMS JY, MADDOX RA, et al. Corticosteroids added to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in high‐risk patients with Kawasaki disease[J]. J Am Heart Assoc, 2020,9(17): e015308., articleTitle=null, refAbstract=null), Reference(id=1326651765325410704, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[38], rfOrder=37, authorNames=null, journalName=null, refType=null, unstructuredReference=ZHU BH, LYU HT, SUN L, et al. A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease[J]. Eur J Pediatr, 2012, 171(3): 571-578., articleTitle=null, refAbstract=null), Reference(id=1326651765400908177, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[39], rfOrder=38, authorNames=null, journalName=null, refType=null, unstructuredReference=李静, 王博龙, 冯瑞冰, 等. 糖皮质激素联合免疫球蛋白用于川崎病初始治疗有效性的Meta分析[J]. 中国当代儿科杂志, 2016, 18(6): 527-533., articleTitle=null, refAbstract=null), Reference(id=1326651765480599954, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[40], rfOrder=39, authorNames=null, journalName=null, refType=null, unstructuredReference=杜忠东, 张维华, 杨晓东, 等. 糖皮质激素在川崎病治疗中的儿科专家共识[J]. 中国当代儿科杂志, 2022, 24(3): 225-231., articleTitle=null, refAbstract=null), Reference(id=1326651765547708819, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[41], rfOrder=40, authorNames=null, journalName=null, refType=null, unstructuredReference=CHEN J, LIAO J, XIANG L, et al. Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review[J]. Frontiers in Immunology, 2023, 14: 1237670., articleTitle=null, refAbstract=null), Reference(id=1326651765614817684, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[42], rfOrder=41, authorNames=null, journalName=null, refType=null, unstructuredReference=BURNS JC, ROBERTS SC, TREMOULET AH, et al.Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA(KIDCARE): a randomised, multicentre comparative effectiveness trial[J]. Lancet Child Adolesc Health, 2021,5(12): 852-861., articleTitle=null, refAbstract=null), Reference(id=1326651765694509461, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[43], rfOrder=42, authorNames=null, journalName=null, refType=null, unstructuredReference=MIYATA K, BAINTO EV, SUN X, et al. Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis[J]. Arch Dis Child, 2023, 108(10): 833-838., articleTitle=null, refAbstract=null), Reference(id=1326651765778395542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[44], rfOrder=43, authorNames=null, journalName=null, refType=null, unstructuredReference=CHENG H. Assessing the efficacy of infliximab in promoting vascular and mucosal healing in immunoglobulin-resistant kawasaki disease: a meta-analysis[J]. Bio Med Central Pediatrics, 2025, 25(1): 147., articleTitle=null, refAbstract=null), Reference(id=1326651765862281623, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[45], rfOrder=44, authorNames=null, journalName=null, refType=null, unstructuredReference=PORTMAN MA, DAHDAH NS, SLEE A, et al. Etanercept with IVIG for acute Kawasaki disease: a randomized controlled trial[J]. Pediatrics, 2019, 143(6): e20183675., articleTitle=null, refAbstract=null), Reference(id=1326651765933584792, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[46], rfOrder=45, authorNames=null, journalName=null, refType=null, unstructuredReference=SAGIV E, SLEE A, BUFFONE A, et al. Etanercept with IVIg for acute Kawasaki disease: a long-term follow-up on the EATAK trial[J]. Cardiol Young, 2023, 33(4): 613-618., articleTitle=null, refAbstract=null), Reference(id=1326651766004887961, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[47], rfOrder=46, authorNames=null, journalName=null, refType=null, unstructuredReference=ROGERS R, SAGIV E, OLSON AK, et al. Five-year experience of etanercept as adjunct to intravenous immunoglobulin for Kawasaki disease with coronary artery involvement[J]. J Pediatr Clin Pract, 2025, 17: 200165., articleTitle=null, refAbstract=null), Reference(id=1326651766084579738, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[48], rfOrder=47, authorNames=null, journalName=null, refType=null, unstructuredReference=KONE‐PAUT I, TELLIER S, BELOT A, et al. Phase Ⅱopen label study of anakinra in intravenous immunoglobulin-resistant Kawasaki disease[J]. Arthritis Rheumatol, 2021,73(1): 151-161., articleTitle=null, refAbstract=null), Reference(id=1326651766151688603, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[49], rfOrder=48, authorNames=null, journalName=null, refType=null, unstructuredReference=MURAYAMA Y, HAMADA H, SHIKO Y, et al. Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment[J]. Front Pediatr, 2023, 11: 1321533., articleTitle=null, refAbstract=null), Reference(id=1326651766248157596, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[50], rfOrder=49, authorNames=null, journalName=null, refType=null, unstructuredReference=MANLHIOT C, NEWBURGER JW, LOW T, et al. Low-molecular-weight heparin vs warfarin for thromboprophylaxis in children with coronary artery aneurysms after Kawasaki disease: a pragmatic registry trial[J]. Can J Cardiol, 2020,36(10): 1598-1607., articleTitle=null, refAbstract=null), Reference(id=1326651766353015197, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[51], rfOrder=50, authorNames=null, journalName=null, refType=null, unstructuredReference=BAKER AL, VANDERPLUYM C, GAUVREAU KA, et al. Safety and efficacy of warfarin therapy in Kawasaki disease[J]. J Pediatr, 2017, 189: 61-65., articleTitle=null, refAbstract=null), Reference(id=1326651766441095582, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[52], rfOrder=51, authorNames=null, journalName=null, refType=null, unstructuredReference=SHIMIZU C, KIM J, HE M, et al. RNA sequencing reveals beneficial effects of atorvastatin on endothelial cells in acute Kawasaki disease[J]. J Am Heart Assoc, 2022, 11(14):e025408., articleTitle=null, refAbstract=null), Reference(id=1326651766554341791, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[53], rfOrder=52, authorNames=null, journalName=null, refType=null, unstructuredReference=TREMOULET AH, JAIN S, JONE PN, et al. Phase Ⅰ/Ⅱa trial of atorvastatin in patients with acute Kawasaki disease with coronary artery aneurysm[J]. J Pediatr, 2019, 215: 107-117., articleTitle=null, refAbstract=null), Reference(id=1326651768232063393, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[54], rfOrder=53, authorNames=null, journalName=null, refType=null, unstructuredReference=SALIBA T, NEVESNY F, ANTIOCHOS P, et al. Progressive coronary aneurysms in Kawasaki disease: a case report and long-term follow-up[J]. Radiol Case Rep, 2025, 20(5):2459-2462., articleTitle=null, refAbstract=null)], funds=null, companyList=[AuthorCompany(id=1326651756001472842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, xref=null, ext=[AuthorCompanyExt(id=1326651756009861451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China), AuthorCompanyExt(id=1326651756035027276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.12.003, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2025.12.003, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2025.12.003, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2025.12.003, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1765296000000, fullTextJson=null, articleText=null, reference=null)
收藏切换
川崎病药物治疗研究进展
王慧婧 , 黄卫华 * , 赵惠君
世界临床药物 | 医药专论 2025,46(12): 1213-1220
收起
收藏切换
世界临床药物 |医药专论 2025 , 46 (12) : 1213 -1220
川崎病药物治疗研究进展
全屏
[Author(id=1326651756211188046, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326651756307657040, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756211188046, language=EN, stringName=Huijing WANG, firstName=Huijing, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326651756374765905, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756211188046, language=CN, stringName=王慧婧, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028, bio={"content":"

王慧婧,主治医师,研究方向:儿童血液病。

"}, bioImg=null, bioContent=

王慧婧,主治医师,研究方向:儿童血液病。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326651756001472842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, xref=null, ext=[AuthorCompanyExt(id=1326651756009861451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China), AuthorCompanyExt(id=1326651756035027276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028)])]), Author(id=1326651756471234899, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1326651756634812757, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756471234899, language=EN, stringName=Weihua HUANG, firstName=Weihua, middleName=null, lastName=HUANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326651756852916566, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756471234899, language=CN, stringName=黄卫华, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326651756001472842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, xref=null, ext=[AuthorCompanyExt(id=1326651756009861451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China), AuthorCompanyExt(id=1326651756035027276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028)])]), Author(id=1326651756924219736, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, orderNo=2, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1326651757071020378, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756924219736, language=EN, stringName=Huijun ZHAO, firstName=Huijun, middleName=null, lastName=ZHAO, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1326651757171683675, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, authorId=1326651756924219736, language=CN, stringName=赵惠君, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1326651756001472842, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, xref=null, ext=[AuthorCompanyExt(id=1326651756009861451, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China), AuthorCompanyExt(id=1326651756035027276, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1326651753577165126, companyId=1326651756001472842, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028)])])]
王慧婧, 黄卫华*, 赵惠君
作者信息
  • 上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028
通讯作者:
黄卫华,主任医师,研究方向:儿童血液病。
作者简介:

王慧婧,主治医师,研究方向:儿童血液病。

Research advances in pharmacotherapy for Kawasaki disease
Huijing WANG, Weihua HUANG*, Huijun ZHAO
Affiliations
  • Department of Pediatrics, Suzhou Kowloon Hospital, Shanghai Jiao Tong University School of Medicine, Suzhou 215028, Jiangsu Province, China
出版时间: 2025-12-10 doi: 10.13683/j.wph.2025.12.003
文章导航
收藏切换

川崎病(Kawasaki disease,KD)是一种急性、自限性、多系统血管炎性综合征,是发达国家儿童后天性心脏病的首要病因,冠状动脉瘤(coronary artery aneurysm)是其最严重的并发症,可引发远期心血管事件。近年来,对于KD发病机制的认知已从单一病原体假说,转变为将其视为一种由微生物引发的免疫失调性疾病。现基于风险分层的KD个体化治疗模式,系统综述KD药物治疗最新进展,并针对未来研究方向进行展望,以期为临床用药提供参考。

川崎病  /  血管炎  /  药物治疗  /  静脉注射免疫球蛋白  /  冠状动脉瘤

Kawasaki disease(KD) is an acute, self-limiting, multi-system vasculitic syndrome. It is the leading cause of acquired heart disease in children in developed countries. Coronary artery aneurysms are its most serious complication and can trigger long-term cardiovascular events. In recent years, the understanding of the pathogenesis of KD has shifted from the single pathogen hypothesis to an immune-disordered disease caused by microorganisms. Based on the individualized treatment model of KD with risk stratification, this paper systematically reviewed the latest advances in pharmacotherapy for KD, and prospected the future research directions, aiming to provide reference for clinical medication.

Kawasaki disease  /  vasculitis  /  pharmacotherapy  /  intravenous immunoglobulin  /  coronary artery aneurysm
王慧婧, 黄卫华, 赵惠君. 川崎病药物治疗研究进展. 世界临床药物, 2025 , 46 (12) : 1213 -1220 . DOI: 10.13683/j.wph.2025.12.003
Huijing WANG, Weihua HUANG, Huijun ZHAO. Research advances in pharmacotherapy for Kawasaki disease[J]. World Clinical Drug, 2025 , 46 (12) : 1213 -1220 . DOI: 10.13683/j.wph.2025.12.003

参考文献 引证文献
排序方式:
[1]
RAJASEKARAN K, DURAIYARASAN S, ADEFUYE M,et al. Kawasaki disease and coronary artery involvement: a narrative review[J]. Cureus, 2022, 14(8): e28358.
[2]
MADDOX RA, PERSON MK, KENNEDY JL, et al.Kawasaki disease and Kawasaki disease shock syndrome hospitalization rates in the United States, 2006—2018[J].Pediatr Infect Dis J, 2021, 40(4): 284-288.
[3]
WATTS RA, HATEMI G, BURNS JC, et al. Global epidemiology of vasculitis[J]. Nat Rev Rheumatol, 2022,18(1): 22-34.
[4]
HOUSKA N, ALBERTZ M, ING R. Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association[J]. J Cardiothorac Vasc Anesth, 2025, 39(5): 1103-1105.
[5]
HARA T, NAKASHIMA Y, SAKAI Y, et al. Kawasaki disease: a matter of innate immunity[J]. Clin Exp Immunol,2016, 186(2): 134-143.
[6]
NADIG P, JOSHI V, PILANIA R, et al. Intravenous immunoglobulin in Kawasaki disease - evolution and pathogenic mechanisms[J]. Diagnostics, 2023, 13(14):2338.
[7]
CHRIST A, LATZ E. Deciphering how NLRP3 incites the stromal response in Kawasaki vasculitis[J]. Circ Res,129(9): 840-842.
[8]
LEE JK. Hygiene hypothesis as the etiology of Kawasaki disease: dysregulation of early B cell development[J]. Int J Mol Sci, 2021, 22(22): 12334.
[9]
HALYABAR O, FRIEDMAN KG, SUNDEL RP, et al.Cyclophosphamide use in treatment of refractory Kawasaki disease with coronary artery aneurysms[J]. Pediatr Rheumatol Online J, 2021, 19(1): 31.
[10]
QIU Y, ZHANG Y, LI Y, et al. Molecular mechanisms of endothelial dysfunction in Kawasaki-disease-associated vasculitis[J]. Front Cardiovasc Med, 2022, 9: 981010.
[11]
KIM JJ, KIM HJ, YU JJ, et al. IgA levels are associated with coronary artery lesions in Kawasaki disease[J]. Korean Circ J, 2021, 51(3): 267-268.
[12]
ZHANG Y, JIA C, GUO M, et al. Platelet-monocyte aggregate instigates inflammation and vasculopathy in Kawasaki disease[J]. Adv Sci, 2025, 12(5): e2406282.
[13]
KOCATURK B, LEE Y, NOSAKA N, et al. Platelets exacerbate cardiovascular inflammation in a murine model of Kawasaki disease vasculitis[J]. JCI Insight, 2023, 8(14):e169855.
[14]
KINUMAKI A, SEKIZUKA T, HAMADA H, et al.Characterization of the gut microbiota of Kawasaki disease patients by metagenomic analysis[J]. Front Microbiol, 2015,6: 824.
[15]
KHAN I, LI X ANG, LAW B, et al. Correlation of gut microbial compositions to the development of Kawasaki disease vasculitis in children[J]. Future Microbiol, 2020,15(8): 591-600.
[16]
JENA PK, ARDITI M, NOVAL RIVAS M. Gut microbiota alterations in patients with Kawasaki disease[J]. ATVB,2025, 45(3): 345-358.
[17]
YANG Q, TANG W, REN J, et al. Unveiling the gut-heart potential connection: microbiota's role in Kawasaki disease and coronary artery lesions[J]. Front Cell Infect Microbiol,2025, 15: 1560083.
[18]
WANG F, QIAN F, ZHANG Q, et al. The reduced SCFA-producing gut microbes are involved in the inflammatory activation in Kawasaki disease[J]. Front Immunol, 2023, 14:1124118.
[19]
中华医学会儿科学分会心血管学组. 川崎病诊断和急性期治疗专家共识[J]. 中华儿科杂志, 2022, 60(8): 6-13.
[20]
SALGADO AP, ASHOURI N, BERRY EK, et al. High risk of coronary artery aneurysms in infants younger than 6 months of age with Kawasaki disease[J]. J Pediatr, 2017, 185: 112-116.
[21]
MCCRINDLE BW, ROWLEY AH, NEWBURGER JW, et al.Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association[J]. Circulation, 2017,135(17): e927-e999.
[22]
FUKAZAWA R, KOBAYASHI J, AYUSAWA M, et al.JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease[J]. Circ J, 2020,84(8): 1348-1407.
[23]
MORENO E, GARCIA SD, BAINTO E, et al. Presentation and outcomes of Kawasaki disease in Latin American infants younger than 6 months of age: a multinational multicenter study of the REKAMLATINA network[J]. Front Pediatr,2020, 8: 384.
[24]
CAMERON SA, CARR M, PAHL E, et al. Coronary artery aneurysms are more severe in infants than in older children with Kawasaki disease[J]. Arch Dis Child, 2019, 104(5):451-455.
[25]
LOPEZ L, FROMMELT PC, COLAN SD, et al. Pediatric heart network echocardiographic Z scores: comparison with other published models[J]. J Am Soc Echocardiogr, 2021,34(2): 185-192.
[26]
黄玉娟, 李夙凌, 田园, 等. 中国儿童川崎病诊疗循证指南(2023年)[J]. 中国当代儿科杂志, 2023, 25(12): 1198-1210.
[27]
JIAO W, WEI L, JIAO F, et al. Very early onset of coronary artery aneurysm in a 3-month infant with Kawasaki disease:a case report and literature review[J]. Ital J Pediatr, 2023,49(1): 60.
[28]
Bruggeman CW, Nagelkerke SQ, Lau W, et al. Reatment-associated hemolysis in Kawasaki disease: association with blood-group antibody titers in IVIG products[J]. Blood Adv,2020, 4(14): 3416-3426.
[29]
VAN ANH KVY, SHAH S, Tremoulet AH. Hemolysis from intravenous immunoglobulin in obese patients with Kawasaki disease[J]. Front Pediatr, 2020, 8: 146.
[30]
KIM GB, YU JJ, YOON KL, et al. Medium- or higher-dose acetylsalicylic acid for acute Kawasaki disease and patient outcomes[J]. J Pediatr, 2017, 184: 125-129.
[31]
SUZUKI T, MICHIHATA N, HASHIMOTO Y, et al.Association between aspirin dose and outcomes in patients with acute Kawasaki disease: a nationwide retrospective cohort study in Japan[J]. Eur J Pediatr, 2023, 183(1): 415-424.
[32]
DALLAIRE F, FORTIER-MORISSETTE Z, BLAIS S, et al. Aspirin dose and prevention of coronary abnormalities in Kawasaki disease[J]. Pediatrics, 2017, 139(6): e20170098.
[33]
AMARILYO G, KOREN Y, BRIK SIMON D, et al. High-dose aspirin for Kawasaki disease: outdated myth or effective aid?[J]. Clin Exp Rheumatol, 2017, 35(Suppl 103):S209-S212.
[34]
ZHOU X, DONG R, WEI X, et al. Impact of different treatment strategies on therapeutic efficacy and biomarkers in children with IVIG-resistant Kawasaki disease: a retrospective cohort study[J]. Front Pharmacol, 2025, 16: 1602637.
[35]
MARCHESI A, RIGANTE D, CIMAZ R, et al. Revised recommendations of the Italian society of pediatrics about the general management of Kawasaki disease[J]. Ital J Pediatr,2021, 47(1): 16.
[36]
DE GRAEFF N, GROOT N, OZEN S, et al. European consensus-based recommendations for the diagnosis and treatment of Kawasaki disease - the SHARE initiative[J].Rheumatology, 2019, 58(4): 672-682.
[37]
AE R, ABRAMS JY, MADDOX RA, et al. Corticosteroids added to initial intravenous immunoglobulin treatment for the prevention of coronary artery abnormalities in high‐risk patients with Kawasaki disease[J]. J Am Heart Assoc, 2020,9(17): e015308.
[38]
ZHU BH, LYU HT, SUN L, et al. A meta-analysis on the effect of corticosteroid therapy in Kawasaki disease[J]. Eur J Pediatr, 2012, 171(3): 571-578.
[39]
李静, 王博龙, 冯瑞冰, 等. 糖皮质激素联合免疫球蛋白用于川崎病初始治疗有效性的Meta分析[J]. 中国当代儿科杂志, 2016, 18(6): 527-533.
[40]
杜忠东, 张维华, 杨晓东, 等. 糖皮质激素在川崎病治疗中的儿科专家共识[J]. 中国当代儿科杂志, 2022, 24(3): 225-231.
[41]
CHEN J, LIAO J, XIANG L, et al. Current knowledge of TNF-α monoclonal antibody infliximab in treating Kawasaki disease: a comprehensive review[J]. Frontiers in Immunology, 2023, 14: 1237670.
[42]
BURNS JC, ROBERTS SC, TREMOULET AH, et al.Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA(KIDCARE): a randomised, multicentre comparative effectiveness trial[J]. Lancet Child Adolesc Health, 2021,5(12): 852-861.
[43]
MIYATA K, BAINTO EV, SUN X, et al. Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis[J]. Arch Dis Child, 2023, 108(10): 833-838.
[44]
CHENG H. Assessing the efficacy of infliximab in promoting vascular and mucosal healing in immunoglobulin-resistant kawasaki disease: a meta-analysis[J]. Bio Med Central Pediatrics, 2025, 25(1): 147.
[45]
PORTMAN MA, DAHDAH NS, SLEE A, et al. Etanercept with IVIG for acute Kawasaki disease: a randomized controlled trial[J]. Pediatrics, 2019, 143(6): e20183675.
[46]
SAGIV E, SLEE A, BUFFONE A, et al. Etanercept with IVIg for acute Kawasaki disease: a long-term follow-up on the EATAK trial[J]. Cardiol Young, 2023, 33(4): 613-618.
[47]
ROGERS R, SAGIV E, OLSON AK, et al. Five-year experience of etanercept as adjunct to intravenous immunoglobulin for Kawasaki disease with coronary artery involvement[J]. J Pediatr Clin Pract, 2025, 17: 200165.
[48]
KONE‐PAUT I, TELLIER S, BELOT A, et al. Phase Ⅱopen label study of anakinra in intravenous immunoglobulin-resistant Kawasaki disease[J]. Arthritis Rheumatol, 2021,73(1): 151-161.
[49]
MURAYAMA Y, HAMADA H, SHIKO Y, et al. Risk factors for coronary artery abnormalities and resistance to immunoglobulin plus ciclosporin A therapy in severe Kawasaki disease: subanalysis of the KAICA trial, randomized trial for cicrosporin A as the first-line treatment[J]. Front Pediatr, 2023, 11: 1321533.
[50]
MANLHIOT C, NEWBURGER JW, LOW T, et al. Low-molecular-weight heparin vs warfarin for thromboprophylaxis in children with coronary artery aneurysms after Kawasaki disease: a pragmatic registry trial[J]. Can J Cardiol, 2020,36(10): 1598-1607.
[51]
BAKER AL, VANDERPLUYM C, GAUVREAU KA, et al. Safety and efficacy of warfarin therapy in Kawasaki disease[J]. J Pediatr, 2017, 189: 61-65.
[52]
SHIMIZU C, KIM J, HE M, et al. RNA sequencing reveals beneficial effects of atorvastatin on endothelial cells in acute Kawasaki disease[J]. J Am Heart Assoc, 2022, 11(14):e025408.
[53]
TREMOULET AH, JAIN S, JONE PN, et al. Phase Ⅰ/Ⅱa trial of atorvastatin in patients with acute Kawasaki disease with coronary artery aneurysm[J]. J Pediatr, 2019, 215: 107-117.
[54]
SALIBA T, NEVESNY F, ANTIOCHOS P, et al. Progressive coronary aneurysms in Kawasaki disease: a case report and long-term follow-up[J]. Radiol Case Rep, 2025, 20(5):2459-2462.
2025年第46卷第12期
49
12
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2025.12.003
  • 接收时间:2025-10-28
  • 首发时间:2026-11-09
  • 出版时间:2025-12-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2025-10-28
基金
作者信息
    上海交通大学医学院苏州九龙医院儿科,江苏 苏州 215028

通讯作者:

黄卫华,主任医师,研究方向:儿童血液病。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2025.12.003
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏